报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 64.67% | -5.06% | 0.93% | 48/129 | 53.43% | 佰仁医疗 | 88.56% | 行业排名> |
2024-06-30 | 64.07% | -10.13% | 7.76% | 50/129 | 53.65% | 佰仁医疗 | 89.27% | 行业排名> |
2024-03-31 | 59.46% | -19.62% | -10.62% | 55/129 | 53.62% | 佰仁医疗 | 89.28% | 行业排名> |
2023-12-31 | 66.52% | -13.13% | -2.34% | 37/129 | 53.75% | 正海生物 | 89.9% | 行业排名> |
2023-09-30 | 68.11% | -13.62% | -4.46% | 35/129 | 54.06% | 正海生物 | 90.39% | 行业排名> |
2023-06-30 | 71.29% | -10.63% | -3.62% | 24/129 | 53.61% | 正海生物 | 90.3% | 行业排名> |
2023-03-31 | 73.97% | -8.83% | -3.4% | 18/129 | 53.66% | 正海生物 | 89.78% | 行业排名> |
2022-12-31 | 76.58% | -5.66% | -2.89% | 13/129 | 54.04% | 三友医疗 | 90.18% | 行业排名> |
2022-09-30 | 78.86% | -3.65% | -1.15% | 12/129 | 55.13% | 三友医疗 | 90.14% | 行业排名> |
2022-06-30 | 79.77% | -2.91% | -1.68% | 12/129 | 54.78% | 三友医疗 | 90.29% | 行业排名> |
2022-03-31 | 81.13% | 2% | -0.05% | 10/129 | 56.28% | 三友医疗 | 90.73% | 行业排名> |
2021-12-31 | 81.17% | -1.44% | -0.82% | 11/129 | 57.38% | 三友医疗 | 90.5% | 行业排名> |
2021-09-30 | 81.85% | 2% | -0.38% | 11/129 | 59.17% | 三友医疗 | 90.29% | 行业排名> |
2021-06-30 | 82.16% | -0.95% | -0.24% | 10/129 | 58.42% | 正海生物 | 90.78% | 行业排名> |
2020-12-31 | 82.36% | -0.19% | -0.71% | 12/129 | 59.67% | 正海生物 | 91.59% | 行业排名> |
2020-06-30 | 82.95% | 2% | 0.52% | 12/129 | 59.94% | 正海生物 | 92.23% | 行业排名> |
2019-12-31 | 82.52% | 3.73% | 3.73% | 14/129 | 56.37% | 正海生物 | 92.69% | 行业排名> |
2018-12-31 | 79.55% | 7.4% | 7.4% | 17/129 | 55.53% | 正海生物 | 92.61% | 行业排名> |
2017-12-31 | 74.06% | 2% | 2% | 23/129 | 55.34% | 正海生物 | 94.38% | 行业排名> |